The PHC team has produced several publications, and this page lists a select set of publications.

2019 publications

Safety, efficacy, and cost utility of Zepatier (elbasvir/grazoprevir) in the treatment of chronic hepatitis C in transplant recipients: a systematic literature review and meta analysis. In progress.

Network meta-analysis and systematic literature review of Sotagliflozin (LX4211)  for the treatment of type 1 and 2 diabetes. In progress.

Systematic literature review and network meta-analysis of Itolizumab for moderate-to-severe plaque psoriasis. In progress.

Systematic literature review and network meta-analysis on clinical relevance of immunogenicity in insulin biosimilars/analogues. Finished.

2018 publications

Madani Civi M.Humphries K. A systematic review and meta-analysis to evaluate the clinical evidence of the efficacy of Ranolazine for the treatment of angina pectoris in the absence of obstructive coronary disease. Finished.

Azhir Ava, Madani Civi Rana.Azhir A., Madani Civi M. Safety profile of biologic treatment for moderate-to-severe plaque psoriasis: Systematic literature review and meta-analysis. Submitted in the 27TH EADV Congress, Paris, France, September 12-16, 2018.

2017 publications

A  systematic review and meta-analysis of single-arm trials on the role of targeted therapy in the management of triple-negative breast cancer. Poster presentation at the 3rd World Congress on Controversies in Breast Cancer (CoBrCa), Tokyo, Japan, October 26-28, 2017.

Azhir A. & Madani Civi M. Toxicity profile of targeted therapy as systemic chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Poster session presented at the 4th Canadian Cancer Research Conference, in Vancouver, Canada, Nov. 5-7, 2017.